Top Ten Medical Device Unicorns in China

1. United Imaging Healthcare: A Leading Pioneer in Domestic High-End Equipment

Established in October 2010, United Imaging's headquarters are located in Jiading, Shanghai. Within a few years, through capital investment and technological innovation, it rapidly established a global competitive advantage in the imaging industry, forming multiple product divisions including molecular imaging (MI), computed tomography (CT), radiotherapy (RT), X-ray, and AI intelligence.

Through an open talent development platform, it has gathered hundreds of highly skilled professionals globally. Currently, it has released 14 system products and 4 software products for medical imaging equipment operation services.

Among them, the 96-ring ultra-high-speed PET-CT has filled an international gap with its dual breakthroughs in resolution and scanning speed; the industry's first dynamic multipolar 3.0T MRI ended China's nearly ten-year wait, marking a Chinese first.

The new generation 112-ring PET-CT, the industry's first dual-modality 128-slice CT, and other products remain technologically advanced. With an annual R&D investment of around 18%, United Imaging, this medical imaging unicorn, continues to move forward.

2. Mindray Medical: International Brand, Made in China

Founded in 1991 in Shenzhen, Mindray Medical started as a trading company. Through agency sales, independent R&D, internationalization, and domestic and international mergers and acquisitions, it has built Mindray's three major product lines: monitoring, ultrasound, and testing.

Without exception, Mindray's rapid development is closely related to capital operations, and all three product lines have established cooperation with multinational corporations.

Monitoring was acquired from Datascope in the US, ultrasound from Toshiba in Japan, and testing from Coulter and Beckman in the US. Through mergers and acquisitions, it established technological advantages, valued customer relationships, and operated as an international brand, allowing Mindray to quickly occupy a leading position in China's medical device industry.

Products such as monitors are widely used in high-level hospitals both domestically and internationally. The 'iron triangle' development model is strong domestically, but the annual 10% R&D investment still needs improvement.

3. Lepu Medical: Leader in Drug-Eluting Stents without Carriers

Established in 1999, Lepu Medical was formerly Beijing Lepu Medical Devices Co., Ltd., jointly funded by the Seventh 25th Research Institute of China Shipbuilding Industry Corporation and WP Company of the United States. The latter contributed capital based on the evaluation of two proprietary technologies and production technologies: "catheters for percutaneous transluminal coronary angioplasty" and "stents for expanding blood vessels" (recognized as high-tech achievements by the Beijing Municipal Science and Technology Commission).

Lepu Medical has built a strong technological advantage in drug-eluting stents without carriers. Using a special process, it sprays rapamycin into 300-400nm micropores on the stent and uses proprietary technology to enhance the adsorption of the drug to the nanopores, effectively solving the problem of restenosis within three months after the implantation of bare metal stents and avoiding the problem of late thrombosis of carrier stents. The clinical effect is significant.

Currently, it holds an absolute advantage in this category, with a PE ratio of 66 times and a valuation of 55 billion yuan.

4. DongSoft Medical: Pioneer of Chinese CT

Founded in 1998, Shenyang DongSoft Medical Systems Co., Ltd., as one of the enterprises undertaking the important task of developing China's medical devices, was once highly anticipated by the state as the "Anke in the south and DongSoft in the north." For a long time, DongSoft lived up to expectations, shouldering the banner of national medical care in the R&D of high-end equipment such as spiral CT and MRI.

In 1997, DongSoft Medical independently developed China's first whole-body CT, breaking the monopoly of international multinational corporations. After countless sleepless nights, DongSoft Medical innovatively developed a PC to replace the array processor, reducing the imaging speed of the CT machine from the initial 58 seconds to 28 seconds, then to 18 seconds, 8 seconds, 5 seconds, and finally to within 1 second.

The existence of DongSoft has resulted in an overall decrease in the Price level of the domestic CT industry by about 30%, directly benefiting the public and patients.

This has become a new milestone in the development history of large-scale high-end medical equipment in China, and it also marks the end of the era when core technologies of CT products were monopolized by a few foreign companies.

In the field of CT products, it continues to lead the domestic CT industry: the market share of dual-slice CT is among the top; 16-slice CT is among the top; in 2015, it pioneered the development of China's 128-slice spiral CT with independent intellectual property rights, with half of the orders going to top three hospitals in China. A well-deserved unicorn in the CT category!

5. Yuwell Medical: Leader in Rehabilitation Medical Care

In 1998, Wu Guangming and his father Wu Lianfu jointly founded Jiangsu Yuwell Medical Equipment Co., Ltd., the predecessor of Yuwell Medical. From a township enterprise in southern Jiangsu, under the efforts and wisdom of Wu Guangming and his team, it has become a leader among domestic medical device companies.

From initial wheelchairs to later nursing products and medical oxygen products, Yuwell Medical has achieved rapid development by expanding its product lines.

Establishing the Yuwell Group Jinzhong Germany R&D Center, successively acquiring Germany's Metrax GmbH, the largest defibrillator manufacturer in Europe, and holding a stake in Amsino Medical, focusing on R&D and mergers and acquisitions, the product categories are becoming increasingly rich: the company's own years of persistent R&D investment has yielded results, while acquisitions over the years have brought about the expansion of the product line.

Acquiring Suzhou Medical Supplies Factory, integrating and revitalizing the brand of a time-honored Chinese brand; acquiring Shangxie Group, extending the product line to surgical instruments and sanitary materials; acquiring Zhongyou Pharmaceutical, expanding disinfection products and services, and cooperating with Shangxie to develop the market, etc., have made Yuwell quickly become a unicorn enterprise in the industry's rehabilitation care, medical oxygen, and medical clinical series medical devices.

6. Kailite Bio: Pioneer and Leader of Chinese Ultrasound

Located in Yuezhuan Road, Yizhe Building, Nanshan District, Shenzhen, Kailite BioMedical was founded in 2002.

It has pioneered many firsts in China's ultrasound industry. Kailite is also one of the earliest domestic manufacturers to master the core technologies of color Doppler ultrasound equipment and B-ultrasound equipment. Its color ultrasound technology is leading in the domestic industry, and it has been the first to Enter the high-barrier European and American markets internationally, and its product series are gradually extending from the low-to-mid-end to the high-end.

Kailite Medical has more than 20 ultrasound imaging products, equipped with self-produced probes, covering multiple medical fields suitable for ultrasound imaging diagnosis.

At the same time, in the field of electronic endoscopy, Kailite's independently developed domestic high-definition electronic endoscope allows nearby hospitals to conduct high-definition endoscopic examinations.

Holding 91 invention patents, 62 utility model patents, 51 design patents, 28 non-patent proprietary technologies, and 55 copyrights, the company has become an absolute unicorn company in the field of ultrasound technology and products.

7. Anjian Technology: Pioneer and Leader of China's Dynamic DR

Established in 2002, Anjian Technology is a world-leading supplier of DR medical devices. For sixteen years, it has been deeply involved in the DR industry, promoting the digitalization of China's general radiography diagnosis.

Anjian Technology is actively involved in the layout of DR industry technology and focuses on product innovation. It is the first company in China to successfully develop core technologies such as dynamic detectors and high-voltage generators for DR, and launched a diagnostically excellent dynamic DR globally. This has pushed Chinese DR from traditional static diagnosis to more accurate dynamic diagnosis, effectively reducing misdiagnosis.

It has also effectively reduced the Price of DR products monopolized by foreign medical giants by 50%, making DR an important screening and diagnostic equipment for a large number of county and grassroots hospitals in China. The product has achieved an installed base of 7,000 units in China, leading the industry. Among them, the installed base of dynamic DR has exceeded 2,000 units, making it a pioneer and absolute leader in the dynamic DR segment.

The large-format, real-time high-definition spot imaging, visualization, dynamic video playback and saving functions of dynamic DR make screening and diagnosis of general radiography more accurate and efficient. The product is exported to more than 30 countries and regions including Southeast Asia, Europe, Central Asia, America, and Africa, and is a new unicorn in China's DR industry. It has become the pioneer and leader of China's dynamic DR industry.

8. Xien Technology: Leader in Cardiac Occlusion Products

Founded in 1999, Xien Technology is a leading supplier of minimally invasive cardiovascular and peripheral vascular medical devices.

Products are sold to Europe, South America, Asia, and Africa. The market share of congenital heart disease occluders has reached the second place globally. Xien's unicorn journey has gone through a process of imitation-improvement-independent innovation. The congenital heart disease occluder is a classic example of the company's product improvement and innovation.

Xien's first-generation products were mainly imitations. The second-generation products are based on material innovation, using the world's first nano-titanium nitride coating to effectively reduce the release of metal ions into the human body and reduce the risk of thrombosis.

The third-generation occluder improves the product structure, making the operation more convenient. Currently, the products have been sold in more than 80 countries, becoming a leader in technology and products in the field of domestic atrial septal occluders.

9. Libang Instrument: Pioneer and Leader in Fetal Monitoring and ECG Products

In 1995, Libang Instrument was established in Shenzhen. Through long-term independent research and development and investment, it has become an absolute leader in the field of fetal monitoring and ECG products.

Taking fetal monitoring products as an example, the newly launched ultrasound Doppler fetal monitoring system FTS-6—called "windmill" by doctors—FTS-6 ultrasound Doppler fetal monitoring system has fundamentally changed the fetal monitoring workflow; one device is equivalent to eight traditional fetal monitors.

In the era of the full liberalization of the two-child policy, the launch of this product will have a very significant effect in reducing the workload of obstetric medical and nursing staff and reducing the pressure on hospitals for pregnant women seeking medical treatment.

The launch of the product will also bring a huge impact to the traditional fetal monitoring market, not only improving the product's competitive advantage but also prompting Libang Instrument's own fetal monitoring products to continuously innovate.

In the ECG field, the SE-18 digital eighteen-lead electrocardiograph is Libang Instrument's most high-end ECG product. This product is also one of the few truly eighteen-lead electrocardiographs in the industry, and its clinical value mainly lies in the diagnosis of chest pain.

In the ECG field, Libang Instrument has the SEMIP ECG automatic measurement and analysis algorithm patent technology, which has passed the internationally recognized authoritative ECG database (European CSE database, American AHA database, American MIT database) certification and is at the international leading level.

Currently, Libang Instrument's fetal monitoring and ECG products have the highest market share in China, making it an undisputed unicorn company in this field.

10. MicroPort Medical: A Global Leader in Cardiovascular Devices

MicroPort Medical originated from Shanghai MicroPort Medical Device (Group) Co., Ltd., established in 1998. It has more than 260 products on the market, covering ten areas: cardiovascular intervention, orthopedics implantation and repair, cardiac rhythm management, electrophysiology medical, large artery and peripheral vascular intervention, neurointervention, diabetes and endocrine management, and surgical operations.

MicroPort Medical's products have Entered more than 5,000 hospitals worldwide, covering major markets in Asia-Pacific, Europe, and America. Globally, on average, every 12 seconds, a MicroPort Medical product is used to save a patient's life, improve their quality of life, or help them bring new life into the world.

Among them, the coronary drug-eluting stent product is the first domestically produced drug-eluting stent system. Since its launch in 2004, it has consistently maintained a leading market share in China. The world's first drug-targeted eluting stent system launched in 2014 enabled MicroPort Medical to make a transition from follower to leader in the coronary stent field.

In the field of orthopedic joints, MicroPort Medical's market share currently ranks fifth in the world. By focusing on independent innovation, it has more than 3,000 patents (applications) and multiple products have won national and provincial and ministerial honors such as the National Science and Technology Progress Second Prize. It has established production and R&D bases in Shanghai, Jiangsu, Zhejiang, Beijing, Shenzhen, and Memphis, USA.

Through overseas mergers and acquisitions and joint ventures, MicroPort Medical is gradually promoting the globalization of its industrial layout. Nearly half of the company's more than 4,500 employees are overseas employees, making it a hidden medical unicorn in China.